Vascular endothelial growth factor and renal cell carcinoma / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 148-151, 2012.
Article
in Chinese
| WPRIM
| ID: wpr-418079
ABSTRACT
Vascular endothelial growth factor(VEGF) is high expressed in the organization of renal cell carcinoma and is mainly regulated by VHL gene and hypoxic of organization.Moreover,it can be used as a biomarker to judge renal cell carcinoma tumor progression and prognostic.In recent years,anti-VEGF targeted drugs are used for the treatment of renal cell carcinoma and receive meaningful clinical benefits.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS